These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4628030)

  • 1. [Index of "unbound" thyroxine in patients with hypercholesterolemia or hypertriglyceridemia treated with clofibrate].
    Felt V; Strasek J; Bednár J
    Cas Lek Cesk; 1972 Sep; 111(40):929-31. PubMed ID: 4628030
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H
    Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypolipaemic drugs and coronary heart disease.
    Howard AN
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term treatment of hyperlipidemic patients with clofibrate.
    Berkowitz D
    JAMA; 1971 Nov; 218(7):1002-5. PubMed ID: 5000568
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
    Wolfram G; Keller C; Kilani S; Zöllner N
    Dtsch Med Wochenschr; 1976 Jan; 101(3):76-81. PubMed ID: 1245160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of symfibrate in the treatment of hyperlipemias. Preliminary data].
    Giuliani A; Trezzini C; Urbinati G; Conti R
    Clin Ter; 1979 Mar; 88(5):481-9. PubMed ID: 466970
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of clofibrate in hyperlipidemia: a controlled trial.
    Ilyas M; Peracha MA; Ali N; Husnain Sherazi SM; Mahmood N
    J Pak Med Assoc; 1978 Sep; 28(9):126-8. PubMed ID: 105169
    [No Abstract]   [Full Text] [Related]  

  • 9. [The mechanisms of action of etophylline-clofibrate in hyperlipidemia].
    Păduraru I; Nechifor M; Dănilă G; Jercă L; Filip M; Iacobovici A; Teslaru E; Filip C; Saramet A
    Rev Med Chir Soc Med Nat Iasi; 1993; 97(1):445-9. PubMed ID: 8153471
    [No Abstract]   [Full Text] [Related]  

  • 10. [The study of clofibrate. The viewpoint of Professor D. Kritchevsky interviewed by V. Fabbrocini].
    Kritchevsky D
    Minerva Med; 1979 Dec; 70(55):3808-9. PubMed ID: 523009
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Fourrier A; Mouton Y
    Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug treatment of hyperlipidemia.
    Spector AA
    J Iowa Med Soc; 1972 Oct; 62(10):524-5 passim. PubMed ID: 5074337
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indications for lipid reducing drugs].
    Faergeman AO
    Ugeskr Laeger; 1976 Jan; 138(5):291-3. PubMed ID: 1251496
    [No Abstract]   [Full Text] [Related]  

  • 14. [Classification and treatment of hyperlipidemia: normolipemic treatments in 1972].
    Cloarec M
    Therapeutique; 1972 Dec; 48(10):653-6. PubMed ID: 4661289
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term management of various hyperlipidemias using clofibrate].
    Studlar M; Pichler O; Kindler K
    Wien Med Wochenschr; 1975 Dec; 125(50-52):746-51. PubMed ID: 1229130
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and therapeutic evaluation of a new antilipemic substance].
    de Aguiar Magano L
    Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hyperlipidemias. Value of a new hypolipidemic drug clofibride, (M-G. 46)].
    Leutenegger M; Choisy H; Caron J; Paris H
    Therapie; 1974; 29(4):599-610. PubMed ID: 4439371
    [No Abstract]   [Full Text] [Related]  

  • 20. Diet and drug therapy for hyperlipoproteinemia.
    Maha GE
    Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.